Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports.

Orsolini L, Corkery JM, Chiappini S, Guirguis A, Vento A, De Berardis D, Papanti D, Schifano F.

Curr Neuropharmacol. 2020 Jan 10. doi: 10.2174/1570159X18666200110121333. [Epub ahead of print]

PMID:
31933443
2.

The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Orsolini L, Chiappini S, Papanti D, De Berardis D, Corkery JM, Schifano F.

Front Psychiatry. 2019 Nov 20;10:851. doi: 10.3389/fpsyt.2019.00851. eCollection 2019. Review.

3.

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.

Orsolini L, Chiappini S, Corkery JM, Guirguis A, Papanti D, Schifano F.

Expert Rev Neurother. 2019 Dec;19(12):1253-1264. doi: 10.1080/14737175.2019.1666712. Epub 2019 Sep 24.

PMID:
31503507
4.

Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Deligianni E, Daniel OJ, Corkery JM, Schifano F, Lione LA.

Br J Clin Pharmacol. 2019 Sep 8. doi: 10.1111/bcp.14123. [Epub ahead of print]

PMID:
31495968
5.

Characteristics of deaths associated with kratom use.

Corkery JM, Streete P, Claridge H, Goodair C, Papanti D, Orsolini L, Schifano F, Sikka K, Körber S, Hendricks A.

J Psychopharmacol. 2019 Sep;33(9):1102-1123. doi: 10.1177/0269881119862530. Epub 2019 Aug 20.

PMID:
31429622
6.

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.

Schifano F, Chiappini S, Corkery JM, Guirguis A.

Int J Neuropsychopharmacol. 2019 Apr 1;22(4):270-277. doi: 10.1093/ijnp/pyz007.

7.

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review.

Orsolini L, Ciccarese M, Papanti D, De Berardis D, Guirguis A, Corkery JM, Schifano F.

Front Psychiatry. 2018 May 22;9:153. doi: 10.3389/fpsyt.2018.00153. eCollection 2018. Review.

8.

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Schifano F, Chiappini S, Corkery JM, Guirguis A.

Brain Sci. 2018 Apr 22;8(4). pii: E73. doi: 10.3390/brainsci8040073. Review.

9.

An index of fatal toxicity for new psychoactive substances.

King LA, Corkery JM.

J Psychopharmacol. 2018 Jul;32(7):793-801. doi: 10.1177/0269881118754709. Epub 2018 Feb 27.

PMID:
29482434
10.

Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors.

Corkery JM, Loi B, Claridge H, Goodair C, Schifano F.

Curr Drug Metab. 2018;19(13):1086-1099. doi: 10.2174/1389200218666171108163817. Review.

PMID:
29119924
11.

An exploratory study of information sources and key findings on UK cocaine-related deaths.

Corkery JM, Claridge H, Goodair C, Schifano F.

J Psychopharmacol. 2017 Aug;31(8):996-1014. doi: 10.1177/0269881117711923. Epub 2017 Jun 26.

PMID:
28648101
12.

Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

Schifano F, Guarino V, Papanti DG, Baccarin J, Orsolini L, Corkery JM.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2595. Epub 2017 May 18. Review.

PMID:
28517911
13.

An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS).

Deligianni E, Corkery JM, Schifano F, Lione LA.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2581. Epub 2017 May 8.

PMID:
28485125
14.

Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.

Caloro M, Calabrò G, Kotzalidis GD, Cuomo I, Corkery JM, Vento AE, Lionetto L, De Filippis S, Ranieri V, Lonati D, Locatelli CA, de Pisa E, Di Tommaso A, Girardi P, Schifano F.

Addict Behav. 2016 Sep;60:53-7. doi: 10.1016/j.addbeh.2016.03.032. Epub 2016 Apr 6.

PMID:
27088514
15.

Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.

Schifano F, Papanti GD, Orsolini L, Corkery JM.

Expert Rev Clin Pharmacol. 2016 Jul;9(7):943-54. doi: 10.1586/17512433.2016.1167597. Epub 2016 Apr 4. Review.

PMID:
26985969
16.

Venlafaxine as the 'baby ecstasy'? Literature overview and analysis of web-based misusers' experiences.

Francesconi G, Orsolini L, Papanti D, Corkery JM, Schifano F.

Hum Psychopharmacol. 2015 Jul;30(4):255-61. doi: 10.1002/hup.2476. Review.

PMID:
26216559
17.

Methoxetamine-related deaths in the UK: an overview.

Chiappini S, Claridge H, Corkery JM, Goodair C, Loi B, Schifano F.

Hum Psychopharmacol. 2015 Jul;30(4):244-8. doi: 10.1002/hup.2422.

PMID:
26216557
18.

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.

Corkery JM, Loi B, Claridge H, Goodair C, Corazza O, Elliott S, Schifano F.

Neurosci Biobehav Rev. 2015 Jun;53:52-78. doi: 10.1016/j.neubiorev.2015.03.012. Epub 2015 Apr 3. Review.

PMID:
25843781
19.

Novel psychoactive substances of interest for psychiatry.

Schifano F, Orsolini L, Duccio Papanti G, Corkery JM.

World Psychiatry. 2015 Feb;14(1):15-26. doi: 10.1002/wps.20174.

20.

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse.

Vento AE, Schifano F, Gentili F, Pompei F, Corkery JM, Kotzalidis GD, Girardi P.

Ann Ist Super Sanita. 2013;49(4):402-5. doi: 10.4415/ANN_13_04_14.

Supplemental Content

Loading ...
Support Center